Oncology Treatment Drug Market - Global Outlook and Forecast 2022-2028

March 2022 | 114 pages | ID: O66482649FAEEN
Market Monitor Global

Abstracts

Oncology is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.

This report contains market size and forecasts of Oncology Treatment Drug in Global, including the following market information:

Global Oncology Treatment Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Oncology Treatment Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Oncology Treatment Drug include Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer and Amgen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncology Treatment Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oncology Treatment Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Oncology Treatment Drug Market Segment Percentages, by Type, 2021 (%)

• Chemotherapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)
• Hormonal Therapy
• Others

Global Oncology Treatment Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Oncology Treatment Drug Market Segment Percentages, by Application, 2021 (%)

• Blood Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Respiratory/Lung Cancer
• Others

Global Oncology Treatment Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Oncology Treatment Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Oncology Treatment Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Oncology Treatment Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Celgene
• Novartis
• Bristol-Myers Squibb
• Johnson & Johnson
• Merck & Co.
• AstraZeneca
• Pfizer
• Amgen
• Eli Lilly
• AbbVie
• Takeda
• Astellas
• Ipsen
• Sanofi
• Bayer
• Biogen Idec
• Teva
• Otsuka
• Eisai
• Merck KGaA
• Gilead Sciences

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Oncology Treatment Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Oncology Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ONCOLOGY TREATMENT DRUG OVERALL MARKET SIZE

2.1 Global Oncology Treatment Drug Market Size: 2021 VS 2028
2.2 Global Oncology Treatment Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Oncology Treatment Drug Players in Global Market
3.2 Top Global Oncology Treatment Drug Companies Ranked by Revenue
3.3 Global Oncology Treatment Drug Revenue by Companies
3.4 Top 3 and Top 5 Oncology Treatment Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Oncology Treatment Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Treatment Drug Players in Global Market
  3.6.1 List of Global Tier 1 Oncology Treatment Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Oncology Treatment Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Oncology Treatment Drug Market Size Markets, 2021 & 2028
  4.1.2 Chemotherapy
  4.1.3 Targeted Therapy
  4.1.4 Immunotherapy (Biologic Therapy)
  4.1.5 Hormonal Therapy
  4.1.6 Others
4.2 By Type - Global Oncology Treatment Drug Revenue & Forecasts
  4.2.1 By Type - Global Oncology Treatment Drug Revenue, 2017-2022
  4.2.2 By Type - Global Oncology Treatment Drug Revenue, 2023-2028
  4.2.3 By Type - Global Oncology Treatment Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Oncology Treatment Drug Market Size, 2021 & 2028
  5.1.2 Blood Cancer
  5.1.3 Breast Cancer
  5.1.4 Gastrointestinal Cancer
  5.1.5 Prostate Cancer
  5.1.6 Respiratory/Lung Cancer
  5.1.7 Others
5.2 By Application - Global Oncology Treatment Drug Revenue & Forecasts
  5.2.1 By Application - Global Oncology Treatment Drug Revenue, 2017-2022
  5.2.2 By Application - Global Oncology Treatment Drug Revenue, 2023-2028
  5.2.3 By Application - Global Oncology Treatment Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Oncology Treatment Drug Market Size, 2021 & 2028
6.2 By Region - Global Oncology Treatment Drug Revenue & Forecasts
  6.2.1 By Region - Global Oncology Treatment Drug Revenue, 2017-2022
  6.2.2 By Region - Global Oncology Treatment Drug Revenue, 2023-2028
  6.2.3 By Region - Global Oncology Treatment Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Oncology Treatment Drug Revenue, 2017-2028
  6.3.2 US Oncology Treatment Drug Market Size, 2017-2028
  6.3.3 Canada Oncology Treatment Drug Market Size, 2017-2028
  6.3.4 Mexico Oncology Treatment Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Oncology Treatment Drug Revenue, 2017-2028
  6.4.2 Germany Oncology Treatment Drug Market Size, 2017-2028
  6.4.3 France Oncology Treatment Drug Market Size, 2017-2028
  6.4.4 U.K. Oncology Treatment Drug Market Size, 2017-2028
  6.4.5 Italy Oncology Treatment Drug Market Size, 2017-2028
  6.4.6 Russia Oncology Treatment Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Oncology Treatment Drug Market Size, 2017-2028
  6.4.8 Benelux Oncology Treatment Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Oncology Treatment Drug Revenue, 2017-2028
  6.5.2 China Oncology Treatment Drug Market Size, 2017-2028
  6.5.3 Japan Oncology Treatment Drug Market Size, 2017-2028
  6.5.4 South Korea Oncology Treatment Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Oncology Treatment Drug Market Size, 2017-2028
  6.5.6 India Oncology Treatment Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Oncology Treatment Drug Revenue, 2017-2028
  6.6.2 Brazil Oncology Treatment Drug Market Size, 2017-2028
  6.6.3 Argentina Oncology Treatment Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Oncology Treatment Drug Revenue, 2017-2028
  6.7.2 Turkey Oncology Treatment Drug Market Size, 2017-2028
  6.7.3 Israel Oncology Treatment Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Oncology Treatment Drug Market Size, 2017-2028
  6.7.5 UAE Oncology Treatment Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Oncology Treatment Drug Major Product Offerings
  7.1.4 Roche Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 Celgene
  7.2.1 Celgene Corporate Summary
  7.2.2 Celgene Business Overview
  7.2.3 Celgene Oncology Treatment Drug Major Product Offerings
  7.2.4 Celgene Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.2.5 Celgene Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Oncology Treatment Drug Major Product Offerings
  7.3.4 Novartis Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Bristol-Myers Squibb
  7.4.1 Bristol-Myers Squibb Corporate Summary
  7.4.2 Bristol-Myers Squibb Business Overview
  7.4.3 Bristol-Myers Squibb Oncology Treatment Drug Major Product Offerings
  7.4.4 Bristol-Myers Squibb Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.4.5 Bristol-Myers Squibb Key News
7.5 Johnson & Johnson
  7.5.1 Johnson & Johnson Corporate Summary
  7.5.2 Johnson & Johnson Business Overview
  7.5.3 Johnson & Johnson Oncology Treatment Drug Major Product Offerings
  7.5.4 Johnson & Johnson Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.5.5 Johnson & Johnson Key News
7.6 Merck & Co.
  7.6.1 Merck & Co. Corporate Summary
  7.6.2 Merck & Co. Business Overview
  7.6.3 Merck & Co. Oncology Treatment Drug Major Product Offerings
  7.6.4 Merck & Co. Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.6.5 Merck & Co. Key News
7.7 AstraZeneca
  7.7.1 AstraZeneca Corporate Summary
  7.7.2 AstraZeneca Business Overview
  7.7.3 AstraZeneca Oncology Treatment Drug Major Product Offerings
  7.7.4 AstraZeneca Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.7.5 AstraZeneca Key News
7.8 Pfizer
  7.8.1 Pfizer Corporate Summary
  7.8.2 Pfizer Business Overview
  7.8.3 Pfizer Oncology Treatment Drug Major Product Offerings
  7.8.4 Pfizer Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.8.5 Pfizer Key News
7.9 Amgen
  7.9.1 Amgen Corporate Summary
  7.9.2 Amgen Business Overview
  7.9.3 Amgen Oncology Treatment Drug Major Product Offerings
  7.9.4 Amgen Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.9.5 Amgen Key News
7.10 Eli Lilly
  7.10.1 Eli Lilly Corporate Summary
  7.10.2 Eli Lilly Business Overview
  7.10.3 Eli Lilly Oncology Treatment Drug Major Product Offerings
  7.10.4 Eli Lilly Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.10.5 Eli Lilly Key News
7.11 AbbVie
  7.11.1 AbbVie Corporate Summary
  7.11.2 AbbVie Business Overview
  7.11.3 AbbVie Oncology Treatment Drug Major Product Offerings
  7.11.4 AbbVie Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.11.5 AbbVie Key News
7.12 Takeda
  7.12.1 Takeda Corporate Summary
  7.12.2 Takeda Business Overview
  7.12.3 Takeda Oncology Treatment Drug Major Product Offerings
  7.12.4 Takeda Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.12.5 Takeda Key News
7.13 Astellas
  7.13.1 Astellas Corporate Summary
  7.13.2 Astellas Business Overview
  7.13.3 Astellas Oncology Treatment Drug Major Product Offerings
  7.13.4 Astellas Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.13.5 Astellas Key News
7.14 Ipsen
  7.14.1 Ipsen Corporate Summary
  7.14.2 Ipsen Business Overview
  7.14.3 Ipsen Oncology Treatment Drug Major Product Offerings
  7.14.4 Ipsen Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.14.5 Ipsen Key News
7.15 Sanofi
  7.15.1 Sanofi Corporate Summary
  7.15.2 Sanofi Business Overview
  7.15.3 Sanofi Oncology Treatment Drug Major Product Offerings
  7.15.4 Sanofi Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.15.5 Sanofi Key News
7.16 Bayer
  7.16.1 Bayer Corporate Summary
  7.16.2 Bayer Business Overview
  7.16.3 Bayer Oncology Treatment Drug Major Product Offerings
  7.16.4 Bayer Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.16.5 Bayer Key News
7.17 Biogen Idec
  7.17.1 Biogen Idec Corporate Summary
  7.17.2 Biogen Idec Business Overview
  7.17.3 Biogen Idec Oncology Treatment Drug Major Product Offerings
  7.17.4 Biogen Idec Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.17.5 Biogen Idec Key News
7.18 Teva
  7.18.1 Teva Corporate Summary
  7.18.2 Teva Business Overview
  7.18.3 Teva Oncology Treatment Drug Major Product Offerings
  7.18.4 Teva Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.18.5 Teva Key News
7.19 Otsuka
  7.19.1 Otsuka Corporate Summary
  7.19.2 Otsuka Business Overview
  7.19.3 Otsuka Oncology Treatment Drug Major Product Offerings
  7.19.4 Otsuka Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.19.5 Otsuka Key News
7.20 Eisai
  7.20.1 Eisai Corporate Summary
  7.20.2 Eisai Business Overview
  7.20.3 Eisai Oncology Treatment Drug Major Product Offerings
  7.20.4 Eisai Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.20.5 Eisai Key News
7.21 Merck KGaA
  7.21.1 Merck KGaA Corporate Summary
  7.21.2 Merck KGaA Business Overview
  7.21.3 Merck KGaA Oncology Treatment Drug Major Product Offerings
  7.21.4 Merck KGaA Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.21.5 Merck KGaA Key News
7.22 Gilead Sciences
  7.22.1 Gilead Sciences Corporate Summary
  7.22.2 Gilead Sciences Business Overview
  7.22.3 Gilead Sciences Oncology Treatment Drug Major Product Offerings
  7.22.4 Gilead Sciences Oncology Treatment Drug Revenue in Global Market (2017-2022)
  7.22.5 Gilead Sciences Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Oncology Treatment Drug Market Opportunities & Trends in Global Market
Table 2. Oncology Treatment Drug Market Drivers in Global Market
Table 3. Oncology Treatment Drug Market Restraints in Global Market
Table 4. Key Players of Oncology Treatment Drug in Global Market
Table 5. Top Oncology Treatment Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Oncology Treatment Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Oncology Treatment Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Oncology Treatment Drug Product Type
Table 9. List of Global Tier 1 Oncology Treatment Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology Treatment Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Oncology Treatment Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Oncology Treatment Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Oncology Treatment Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Oncology Treatment Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Oncology Treatment Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Oncology Treatment Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Oncology Treatment Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Oncology Treatment Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Oncology Treatment Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Oncology Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Oncology Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Oncology Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Oncology Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Oncology Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Oncology Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Oncology Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Oncology Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Oncology Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Oncology Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Oncology Treatment Drug Product Offerings
Table 32. Roche Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 33. Celgene Corporate Summary
Table 34. Celgene Oncology Treatment Drug Product Offerings
Table 35. Celgene Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Oncology Treatment Drug Product Offerings
Table 38. Novartis Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 39. Bristol-Myers Squibb Corporate Summary
Table 40. Bristol-Myers Squibb Oncology Treatment Drug Product Offerings
Table 41. Bristol-Myers Squibb Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Oncology Treatment Drug Product Offerings
Table 44. Johnson & Johnson Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 45. Merck & Co. Corporate Summary
Table 46. Merck & Co. Oncology Treatment Drug Product Offerings
Table 47. Merck & Co. Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 48. AstraZeneca Corporate Summary
Table 49. AstraZeneca Oncology Treatment Drug Product Offerings
Table 50. AstraZeneca Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Oncology Treatment Drug Product Offerings
Table 53. Pfizer Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 54. Amgen Corporate Summary
Table 55. Amgen Oncology Treatment Drug Product Offerings
Table 56. Amgen Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 57. Eli Lilly Corporate Summary
Table 58. Eli Lilly Oncology Treatment Drug Product Offerings
Table 59. Eli Lilly Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 60. AbbVie Corporate Summary
Table 61. AbbVie Oncology Treatment Drug Product Offerings
Table 62. AbbVie Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 63. Takeda Corporate Summary
Table 64. Takeda Oncology Treatment Drug Product Offerings
Table 65. Takeda Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 66. Astellas Corporate Summary
Table 67. Astellas Oncology Treatment Drug Product Offerings
Table 68. Astellas Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 69. Ipsen Corporate Summary
Table 70. Ipsen Oncology Treatment Drug Product Offerings
Table 71. Ipsen Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 72. Sanofi Corporate Summary
Table 73. Sanofi Oncology Treatment Drug Product Offerings
Table 74. Sanofi Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 75. Bayer Corporate Summary
Table 76. Bayer Oncology Treatment Drug Product Offerings
Table 77. Bayer Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 78. Biogen Idec Corporate Summary
Table 79. Biogen Idec Oncology Treatment Drug Product Offerings
Table 80. Biogen Idec Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 81. Teva Corporate Summary
Table 82. Teva Oncology Treatment Drug Product Offerings
Table 83. Teva Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 84. Otsuka Corporate Summary
Table 85. Otsuka Oncology Treatment Drug Product Offerings
Table 86. Otsuka Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 87. Eisai Corporate Summary
Table 88. Eisai Oncology Treatment Drug Product Offerings
Table 89. Eisai Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 90. Merck KGaA Corporate Summary
Table 91. Merck KGaA Oncology Treatment Drug Product Offerings
Table 92. Merck KGaA Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 93. Gilead Sciences Corporate Summary
Table 94. Gilead Sciences Oncology Treatment Drug Product Offerings
Table 95. Gilead Sciences Oncology Treatment Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Oncology Treatment Drug Segment by Type in 2021
Figure 2. Oncology Treatment Drug Segment by Application in 2021
Figure 3. Global Oncology Treatment Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Oncology Treatment Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Oncology Treatment Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncology Treatment Drug Revenue in 2021
Figure 8. By Type - Global Oncology Treatment Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Oncology Treatment Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Oncology Treatment Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Oncology Treatment Drug Revenue Market Share, 2017-2028
Figure 12. US Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Oncology Treatment Drug Revenue Market Share, 2017-2028
Figure 16. Germany Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Oncology Treatment Drug Revenue Market Share, 2017-2028
Figure 24. China Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Oncology Treatment Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Oncology Treatment Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Oncology Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Celgene Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol-Myers Squibb Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck & Co. Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AstraZeneca Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Amgen Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Eli Lilly Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. AbbVie Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Takeda Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Astellas Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Ipsen Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Sanofi Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Bayer Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Biogen Idec Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Teva Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Otsuka Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Eisai Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Merck KGaA Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Gilead Sciences Oncology Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)